lysophosphatidic acid has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brindley, DN; Curtis, JM; McMullen, TPW; Meng, G; Tang, X; Yang, Z; Zhao, Y | 1 |
| Murakami, M; Sato, H; Taketomi, Y; Yamamoto, K | 1 |
1 review(s) available for lysophosphatidic acid and Metabolic Syndrome
| Article | Year |
|---|---|
Secreted phospholipase A2 revisited.
Topics: Animals; Arthritis; Catalysis; Glycerophospholipids; Group II Phospholipases A2; Heart Injuries; Humans; Inflammation; Lysophospholipids; Metabolic Syndrome; Mice; Neoplasms; Phospholipases A2; Phospholipids; Respiratory Distress Syndrome; Signal Transduction | 2011 |
1 other study(ies) available for lysophosphatidic acid and Metabolic Syndrome
| Article | Year |
|---|---|
Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
Topics: Adipose Tissue; Animals; Dexamethasone; Female; Humans; Inflammation; Lysophospholipids; Mammary Neoplasms, Experimental; Metabolic Syndrome; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Phosphoric Diester Hydrolases; Signal Transduction | 2019 |